Durect (DRRX -28%) is another casualty of the FDA's rejection of Remoxy. Its technology - designed to discourage common methods of tampering - was used to develop the drug. PTIE -37%, PFE -1.5%.
Durect (DRRX -28%) is another casualty of the FDA's rejection of Remoxy. Its technology -...
Recommended For You
More Trending News
About DRRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| DRRX | - | - |
| DURECT Corporation | ||